Demographic characteristics of people receiving COVID-19 vaccinations in the United States : Percentages of Population Eligible for a First Booster Dose with and without a Booster, by Race/Ethnicity : Population ≥ 65 Years of Age
Demographic characteristics of people receiving COVID-19 vaccinations in the United States : Percentages of Population Eligible for a First Booster Dose with and without a Booster, by Race/Ethnicity : Population ≥ 65 Years of Age
CDC | Data as of: August 10, 2022 6:00am ET. Posted: August 11, 2022
CDC is working with jurisdictions to provide more information on the demographic characteristics of vaccinated people.
Data from 45.64M people ages 65 years and older who are eligible for a booster dose*. Race/ethnicity was available for 35.12M (76.9%) people ages 65 years and older who are eligible for a booster dose.
CDC | Data as of: Monday, August 15, 2022 1:11 PM ET. Posted: Monday, August 15, 2022 2:18 PM ETCDC is working with states to provide more information...
Centers for Disease Control and Prevention (U.S.) ...
August 15, 2022 | COVID Data Tracker
Description:
Time Period: Jul 27, 2022 – Aug 10, 2022CDC | Data as of: Monday, August 15, 2022 1:11 PM ET. Posted: Monday, August 15, 2022 2:18 PM ETMaps, charts...
CDC | Data as of: August 10, 2022 6:00am ET. Posted: August 11, 2022CDC is working with jurisdictions to provide more information on the demographic c...
CDC | Data as of: August 10, 2022 6:00am ET. Posted: August 11, 2022Data from 193.11M people ages 12 years and older who are eligible for a booster do...
National totals as of: Aug 12 2022. National positivity date as of: Aug 12 2022CDC | Data as of: Monday, August 15, 2022 1:11 PM ET. Posted: Monday, A...
National totals as of: Aug 12 2022. National positivity date as of: Aug 12 2022CDC | Data as of: Monday, August 15, 2022 1:11 PM ET. Posted: Monday, A...
CDC | Data as of: Monday, August 15, 2022 1:11 PM ET. Posted: Monday, August 15, 2022 2:18 PM ETThis shows the total number of COVID-19 cases since th...
CDC | Data as of: Monday, August 15, 2022 1:11 PM ET. Posted: Monday, August 15, 2022 2:18 PM ETThis shows the total number of deaths since the pandem...
National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of High-Consequence Pathogens and Pathology.
August 15, 2022 | Interim clinical considerations for use of JYNNEOS and ACAM2000 vaccines during the 2022 U.S. monkeypox outbreak
Description:
supersedes: cdc:120088Updated August 15, 2022This document provides interim guidance for healthcare professionals and public health officials regardin...
National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of High-Consequence Pathogens and Pathology.
August 15, 2022 | Interim clinical considerations for use of JYNNEOS and ACAM2000 vaccines during the 2022 U.S. monkeypox outbreak
Description:
Updated August 15, 2022Formerly called: Interim clinical considerations for use of JYNNEOS and ACAM2000 vaccines during the 2022 U.S. monkeypox outbre...
Data as of: December 9, 2021 6:00am ET. Posted: Thursday, December 9, 2021 8:41 PM ETRepresents all vaccine partners including jurisdictional partner ...
National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
January 5, 2023 | CDC COVID Data Tracker
Description:
CDC | Data as of: January 4, 2023 6:00am ET. Posted: January 5, 2023This shows the percentage of all residents ages residents ages 5 years and older y...
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC)
cannot attest to the accuracy of a non-federal website.
Linking to a non-federal Website does not constitute an
endorsement by CDC or any of its employees of the sponsors
or the information and products presented on the website.
You will be subject to the destination website's privacy
policy when you follow the link.
CDC is not responsible for Section 508 compliance
(accessibility) on other federal or private websites.
For more information on CDC's web notification policies, see Website Disclaimers.